Tag: deep brain stimulation
First UK trial evaluating deep brain stimulation in children with epilepsy...
A UK clinical trial evaluating deep brain stimulation (DBS) in children with epilepsy recently got underway—and a teenager who was the patient to take...
Medtronic receives “landmark” US FDA approval for asleep deep brain stimulation...
Medtronic has received US Food and Drug Administration (FDA) approval of asleep deep brain stimulation (DBS) surgery for people with Parkinson’s disease and people...
Boston Scientific obtains CE mark for image-guided programming software in DBS
Boston Scientific Corporation has obtained a CE mark for the Vercise neural navigator 5 software with STIMVIEW XT technology, which—when used as part of...
Short-pulse DBS appears more effective than conventional DBS in tremor but...
In a systematic review and meta-analysis of the current literature, deep brain stimulation (DBS) with a short pulse width has been shown to potentially...
Study elucidates how patient age and electrode connectivity impact cognitive effects...
A study presented at the recent American Academy of Neurology (AAN) annual meeting (13–18 April, Denver, USA) has gone some way to elucidating how...
Abbott launches Liberta RC deep brain stimulation system with remote programming...
Abbott recently announced that it has received approval from the US Food and Drug Administration (FDA) to launch the Liberta RC deep brain stimulation...
Medtronic gains US FDA approval for Percept RC deep brain stimulation...
Medtronic has announced the US Food and Drug Administration (FDA) approval of its Percept RC deep brain stimulation (DBS) system.
The rechargeable neurostimulator is the...
Evolving the standard of care: What is next for functional neurosurgery?
The proliferation of new technologies and advancements in the neurosciences space has showed little sign of slowing in recent years and—as John Rolston (Boston,...
Surgical Information Sciences initiates VISION study to support DBS for Parkinson’s...
Surgical Information Sciences (SIS) has announced the commencement of its post-market VISION study evaluating visualisation of the subthalamic nucleus (STN) and globus pallidus internus...
Researchers develop non-surgical DBS technology capable of boosting memory accuracy
Researchers at the UK Dementia Research Institute (DRI) have developed a new form of deep brain stimulation (DBS) that does not require surgery and...
Enspire announces publication of trial evaluating DBS plus rehab for stroke...
Enspire DBS Therapy has announced the publication of the results of the EDEN trial—an early feasibility study led by Cleveland Clinic (Cleveland, USA) researchers assessing...
Enspire announces US$17.6 million Series B financing to advance DBS plus...
Enspire DBS Therapy recently announced that it has raised US$17.6 million of committed capital in a Series B financing led by existing investor Cleveland Clinic Innovations....
New spectroscopy probe could enhance deep brain stimulation procedures for Parkinson’s
A new probe that performs two types of spectroscopy could make deep brain stimulation (DBS) procedures safer and improve success rates by helping doctors...
Deep brain stimulation may fulfil “desperate need” for effective Alzheimer’s therapy
A team including researchers from the USA, Germany and Canada has found that stimulating a specific network in the brain of Alzheimer’s disease patients...
Proof-of-concept study indicates utility of evoked-interference DBS in Parkinson’s disease
Closed-loop evoked-interference deep brain stimulation (DBS) has been shown to be potentially utilisable in characterising the role of oscillatory dynamics in Parkinson’s disease and...
Systematic review finds “strong evidence base” supporting deep brain stimulation for...
Deep brain stimulation (DBS) can halve the symptoms of severe obsessive-compulsive disorder (OCD), according to the findings of a pooled data analysis of available...
Aleva Neurotherapeutics gains European MRI approval for deep brain stimulation system
Aleva Neurotherapeutics has announced CE-mark approval of its magnetic resonance imaging (MRI) labelling for the directSTIM deep brain stimulation (DBS) system, allowing the technology...
Abbott receives Breakthrough Device designation to explore DBS in managing severe...
Abbott recently announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation to investigate the use of its deep brain...
INS 2022: Late-breaking research indicates safety of deep brain stimulation in...
Deep brain stimulation (DBS) offers a safe therapy option for reducing chorea in patients with Huntington’s disease, but it remains to be seen whether...
FDA grants Aleva Neurotherapeutics approval for IDE study with directSTIM system
Aleva Neurotherapeutics has received a letter of approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) study assessing...
Patient assent and lack of evidence among key ethical concerns identified...
A study intended to gain insight into prevailing ethical issues surrounding the use of deep brain stimulation (DBS) in adolescents with obsessive-compulsive disorder (OCD)...
Research shows brain rhythm changes occur ‘within minutes’ of DBS surgery...
New research published in Translational Psychiatry presents evidence that brief intraoperative exposure to therapeutic deep brain stimulation (DBS) at the time of implantation surgery induces...
Rune Labs and Medtronic partner to improve understanding of neurostimulation with...
Rune Labs, a company using aggregated brain data to empower the development and delivery of precision medicines for neurological and psychiatric diseases, and global healthcare...
Revolution in neurotherapy? Spotlight on focused ultrasound at 2021 EAN congress
While focused ultrasound is by no means a brand-new innovation in the field of neurotherapy—having first been deployed in the 1950s, if not earlier,...
Allegheny Health Network initiates clinical trial exploring use of DBS to...
A team of physicians at Allegheny Health Network (AHN) in Pittsburgh, USA has received US Food and Drug Administration (FDA) approval to begin the...
Long-term effectiveness of STN-DBS for Parkinson’s confirmed with 15-year follow-up study
New findings published in Neurology, the medical journal of the American Academy of Neurology (AAN), have confirmed the long-term effectiveness of deep brain stimulation...
Benefits found in directional DBS compared to omnidirectional stimulation for Parkinson’s...
Directional deep brain stimulation (DBS) has demonstrated benefits over omnidirectional DBS for the treatment of Parkinson’s disease in the largest prospective study in this...
New algorithm could enable next-generation deep brain stimulation devices
By delivering small electrical pulses directly to the brain, deep brain stimulation (DBS) can ease tremors associated with Parkinson's disease or help relieve chronic...
Medtronic receives CE mark for SenSight directional lead system for DBS...
Medtronic has announced that it has received CE mark for the SenSight directional lead system for deep brain stimulation (DBS) therapy as treatment of...
Vercise Genus DBS system received FDA approval
Boston Scientific has announced that it has received US Food and Drug Administration (FDA) approval for its fourth-generation Vercise Genus deep brain stimulation (DBS) system.
According to a company press release, the...
Medtronic launches aDBS trial in Parkinson’s disease patients
Medtronic has announced the first enrolment in its trial evaluating the safety and efficacy of adaptive deep brain stimulation (aDBS) in patients with Parkinson’s...
Medtronic receives CE mark approval for the Percept PC Neurostimulator deep...
Medtronic announces the CE mark for Percept PC neurostimulator. It is the only Deep Brain Stimulation (DBS) system to be launched in the European...
Aleva Neurotherapeutics receives CE mark for its directSTIM directional Deep Brain...
Aleva Neurotherapeutics has announced that it has been awarded the CE mark for its flagship product, the directSTIM Deep Brain Stimulation System. The system...
First educational module for neuromodulation ensures field is “future-proof”
The first educational module for neuromodulation, a masters-level e-learning course aimed at nurses and allied healthcare professionals working within the field, received its first...
Boston Scientific announces CE mark approval of the VERCISE Neural Navigator...
Boston Scientific has announced the CE mark approval of the Vercise Neural Navigator 3 directional deep brain stimulation (DBS) programming software—the first system that...
The “neurosurgical robot” facilitates further research in deep brain stimulation
The application of robot-assisted lead implantation in nonhuman primate neuromodulation research has been deemed feasible, accurate, safe and efficient in a recent study published...
Medication-free treatment for depression launches in the UK
Flow launches a medication-free treatment for depression comprising a brain stimulation headset and therapy app. In Europe, Flow is classified as a Class IIa...
Review shows inaccuracies of deep brain stimulation data for minimally conscious...
Results from a systematic review reveal that evidence for the use of deep brain stimulation (DBS) of various targets to promote recovery in patients...
International Neuromodulation Society announces 14th World Congress
The International Neuromodulation Society (INS) will hold its 14th World Congress from May 25–30, 2019 in Sydney, Australia. The multidisciplinary meeting highlights top international...
New data show the therapeutic benefits of directional leads for use...
The PROGRESS study has achieved its primary endpoint and demonstrated superiority of the therapeutic window using Abbott directional stimulation compared to omnidirectional stimulation. Results...
Abbott receives CE mark of MR-conditional labelling for Infinity deep brain...
Parkinson’s disease, dystonia and essential tremor patients in CE Mark countries will now benefit from upgraded functionality and new magnetic resonance (MR) conditional labelling...
Deep brain stimulation found to yield “robust but limited” clinical benefits...
A recent study evaluating the efficacy of deep brain stimulation (DBS) in patients with disorders of consciousness reported that robust but limited clinical benefits—predominantly...
Deep brain stimulation associated with a decreased risk of fall in...
Chronic subthalamic deep brain stimulation (DBS) is associated with a decreased risk for recurrent falls and delays the onset of psychosis in patients with...
Deep brain stimulation showing promise for patients with mild Alzheimer’s disease...
An age group analysis of data from the ADvance trial has shown that participants over the age of 65 continue to derive the most...
Positive late-breaking data from the INTREPID study announced
The one-year data from the INTREPID study, the first and only prospective, double-blind, randomised, sham-controlled, multi-centre study of deep brain stimulation (DBS) for advanced,...
Deep brain stimulation shows promise as treatment for Alzheimer’s disease
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and...
Vercise deep brain stimulation system gains FDA approval
The US Food and Drug Administration (FDA) has approved the Vercise deep brain stimulation (DBS) system (Boston Scientific). DBS is used to treat the symptoms...
Aleva Neurotherapeutics raises US$13 million in latest financing round
Aleva Neurotherapeutics has raised US$13 million in a Series D financing round. The round was led by Forrestal Capital, a fund with specific experience...
DBS for chronic neuropathic pain efficacious at three years’ follow-up
A study published in the journal Neuromodulation has shown efficacy at three years’ follow-up for deep brain stimulation (DBS) for the treatment of neuropathic...
SureTune3 earns CE mark for deep brain stimulation therapy
CE mark has been granted to the SureTune3 software (Medtronic) for deep brain stimulation (DBS). SureTune3 provides patient-specific visualisation of lead location and simulated...
Parkinson’s disease patients first to be treated with Leksell Vantage Stereotactic...
The Leksell Vantage Stereotactic system (Elekta) is now in clinical use at three European centres. The first surgeries were performed on a patient with...
CE mark for Vercise Gevia deep brain stimulation system
CE mark has been granted for the Vercise Gevia deep brain stimulation (DBS) system (Boston Scientific), a rechargeable, magnetic resonance (MR) conditional device indicated...
SureTune3 deep brain stimulation software receives Health Canada licence
Medtronic has received a Health Canada licence for SureTune3 software for deep brain stimulation (DBS). The latest innovations in the SureTune technology are designed...
Deep brain stimulation decreases tics in young adults with severe Tourette...
Deep brain stimulation therapy reduces the “tics,” or involuntary movements and vocal outbursts, experienced by young adults with severe cases of Tourette syndrome, according to...
Deep brain stimulation treatment for chronic anorexia is safe and may...
Deep brain stimulation might alter the brain circuits that drive anorexia nervosa symptoms and help improve patients’ mental and physical health, according to a...
Spinal cord stimulation leads to “significant improvement” in gait in Parkinson’s...
A recent study explores the safety and efficacy of spinal cord stimulation on gait disturbance in advanced Parkinson’s disease. The investigators found that spinal...
Infinity deep brain stimulation system approved in the USA
St Jude Medical has announced the United States Food and Drug Administration approval and first implant of the Infinity deep brain stimulation (DBS) system...
Study finds deep brain stimulation a cost-effective treatment method for Parkinson’s...
It has been established that deep brain stimulation is clinically superior to medical therapy for treating advanced Parkinson’s disease. Jan B Pietzsch (Department of...
Medtronic’s StealthStation cranial software receives FDA clearance as an aid for...
Medtronic has announced US Food and Drug Administration (FDA) clearance of StealthStation cranial software as an aid for deep brain stimulation (DBS) lead placement....
CE mark granted to Medtronic for SureTune2 deep brain stimulation therapy
Medtronic has received CE mark for SureTune2 software, which is designed to provide patient-specific visualisation to help physicians make decisions on how to program...
St Jude Medical launches Infinity deep brain stimulation system and directional...
St Jude Medical has launched the Infinity deep brain stimulation (DBS) system and directional DBS lead in Europe.
The system, which received CE mark approval...
Medtronic announces European approval of the first and only full-body MR...
The expanded approval for full-body MRI scans applies to all patients receiving a new system and to an estimated 13,000 people in Europe already receiving Medtronic DBS therapy.
